AI Prediction of Fetal Growth Patterns

Abstract

Recent advances in artificial intelligence (AI) have transformed the landscape of prenatal care, offering innovative methods for predicting fetal growth patterns. This article provides an in-depth review of AI-based prediction models, their clinical relevance, epidemiology, pathophysiology, risk factors, diagnostic considerations, and current management strategies. Emphasis is placed on recent research, emerging technologies, and guideline-based recommendations to inform clinical practice and optimize maternal-fetal outcomes.

Introduction

Fetal growth is a key determinant of perinatal outcomes, with deviations such as fetal growth restriction (FGR) and large for gestational age (LGA) associated with increased morbidity and mortality. Traditional assessment methods, including ultrasound and clinical examination, often lack precision in predicting adverse outcomes. The integration of AI algorithms into obstetric practice promises to enhance the prediction of fetal growth trajectories by assimilating multidimensional data and recognizing complex patterns beyond human cognitive capacity. This article aims to synthesize the current evidence on AI prediction of fetal growth patterns for clinicians seeking to leverage these technologies in perinatal care.

Epidemiology / Disease Burden

Abnormal fetal growth, encompassing both FGR and LGA, remains a significant global health concern. FGR affects approximately 5-10% of pregnancies worldwide and is a leading cause of stillbirth, neonatal morbidity, and long-term neurodevelopmental impairment. LGA, conversely, occurs in 8-12% of pregnancies and is linked with birth trauma, shoulder dystocia, and metabolic complications. Early and accurate prediction of aberrant growth patterns is crucial, as timely intervention can substantially mitigate adverse outcomes. Despite advances in medical technology, a substantial proportion of growth deviations remain undetected until late gestation or at birth, underscoring the necessity for more sophisticated predictive tools such as AI-driven models.

Pathophysiology

Fetal growth is governed by a complex interplay of genetic, placental, maternal, and environmental factors. Disruptions in nutrient and oxygen transfer, placental insufficiency, and maternal comorbidities such as preeclampsia or diabetes can significantly alter fetal growth trajectories. AI models, particularly those employing machine learning and deep learning, offer the capability to integrate large-scale, heterogeneous datasets—including biochemical, biophysical, genetic, and imaging data—to uncover subtle pathophysiological patterns. By modeling interactions among multiple variables, AI can help elucidate underlying mechanisms and potentially identify novel biomarkers predictive of abnormal fetal growth.

Risk Factors

Known risk factors for abnormal fetal growth include maternal age extremes, pre-existing or gestational diabetes, hypertension, smoking, malnutrition, obesity, previous history of FGR or LGA, multiple gestations, and socioeconomic determinants. Traditional risk assessment is limited by its reliance on static variables and population-based cutoffs. AI-driven approaches can dynamically update risk profiles throughout pregnancy by continuously assimilating new clinical, laboratory, and imaging data. This individualized risk stratification enables personalized surveillance and intervention strategies, with the potential to improve both maternal and neonatal outcomes.

Clinical Features

Clinically, FGR often manifests as a discrepancy between gestational age and fundal height, decreased fetal movements, and aberrant Doppler flow patterns on ultrasound. LGA may present with macrosomia on imaging or excessive fundal height. However, these features are nonspecific and frequently lack sensitivity. AI models can enhance early detection by integrating subtle clinical cues with complex data patterns, such as longitudinal growth measurements, maternal demographics, biochemical markers, and advanced imaging features. This multifaceted approach can facilitate earlier identification and targeted management of at-risk pregnancies.

Diagnosis

Standard diagnostic modalities for fetal growth assessment include serial ultrasound biometry, Doppler velocimetry, and maternal serum markers. AI algorithms have been developed to augment these traditional methods by automating image analysis, generating predictive risk scores, and forecasting growth deviations based on historical and real-time data. Recent studies demonstrate that AI models outperform conventional statistical tools in predicting FGR and LGA, with superior sensitivity and specificity. These algorithms can be seamlessly integrated into electronic health record (EHR) systems to provide real-time clinical decision support, reducing diagnostic delays and optimizing resource allocation.

Treatment & Management

The management of abnormal fetal growth hinges on timely recognition and risk stratification. For FGR, interventions may include increased surveillance, optimization of maternal health, antenatal corticosteroids, and consideration of early delivery when indicated. LGA management focuses on glycemic control in diabetic mothers, surveillance for macrosomia, and planning for delivery to minimize birth trauma. AI-driven prediction tools facilitate individualized care pathways by flagging high-risk pregnancies earlier and guiding the frequency and modality of surveillance. Importantly, these tools empower multidisciplinary teams to tailor interventions based on up-to-date risk profiles, potentially reducing unnecessary interventions and associated costs.

Recent Advances / Emerging Therapies

Recent advances in AI include deep learning models capable of analyzing ultrasound images, placental function tests, and integrating multi-omics data for comprehensive risk assessment. Natural language processing (NLP) techniques are being explored to mine unstructured EHR data for additional predictive value. Prospective clinical trials are underway to validate these AI tools in diverse populations and care settings. Furthermore, AI is facilitating the identification of novel therapeutic targets by elucidating molecular mechanisms underlying aberrant fetal growth. The development of explainable AI models is addressing concerns regarding transparency and clinician trust, enabling broader adoption in clinical practice.

Guideline Recommendations

Professional societies, including the American College of Obstetricians and Gynecologists (ACOG) and the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), recognize the potential of AI in obstetric care but emphasize the need for rigorous validation, clinical integration, and ethical oversight. Current guidelines recommend that AI-based prediction tools be used as adjuncts to, rather than replacements for, clinical judgment. Ongoing research and multicenter collaboration are encouraged to establish evidence-based protocols and address challenges related to data privacy, algorithm bias, and equitable access.

Conclusion

The application of AI to predict fetal growth patterns represents a paradigm shift in prenatal care. By leveraging vast and complex datasets, AI models augment traditional risk assessment and diagnostic strategies, enabling earlier identification and individualized management of pregnancies at risk for adverse outcomes. As the field evolves, ongoing collaboration between clinicians, data scientists, and professional organizations will be essential to realize the full potential of these technologies while upholding standards of safety, equity, and clinical efficacy.